Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants

Clinical trial NCT04987333 · COMPLETED

Trial details

NCT number: NCT04987333
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Inflammatory Diseases

Start date: 2021-08-09
Primary completion: 2022-10-03
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.